| William A Morowitz, MD | |
|
107 Berlin Rd, Cherry Hill, NJ 08034-3526 | |
| (856) 429-1800 | |
| (856) 429-1081 |
| Full Name | William A Morowitz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 107 Berlin Rd, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144289315 | NPI | - | NPPES |
| 3734706 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MA26418 (New Jersey) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MA26418 (New Jersey) | Primary |
| Entity Name | Pulmonary And Sleep Associates Of South Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093734022 PECOS PAC ID: 0345285797 Enrollment ID: O20050728000155 |
News Archive
Indonesia has taken the lead in demanding that poor countries have equal access to bird flu vaccines.
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 2099765 to Rexahn, entitled "5, 6, or 7-Substituted-3-arylisoquinolinamine derivatives as antitumor agents."
The National Organization for Rare Disorders and other leading disease and disabilities advocacy groups have filed an amicus brief urging the courts to protect Americans from lawsuits that would undermine protections provided by the nation's new health care reform legislation.
Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.
› Verified 8 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Indonesia has taken the lead in demanding that poor countries have equal access to bird flu vaccines.
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 2099765 to Rexahn, entitled "5, 6, or 7-Substituted-3-arylisoquinolinamine derivatives as antitumor agents."
The National Organization for Rare Disorders and other leading disease and disabilities advocacy groups have filed an amicus brief urging the courts to protect Americans from lawsuits that would undermine protections provided by the nation's new health care reform legislation.
Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William A Morowitz, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | William A Morowitz, MD 107 Berlin Rd, Cherry Hill, NJ 08034-3526 Ph: (856) 429-1800 |
News Archive
Indonesia has taken the lead in demanding that poor countries have equal access to bird flu vaccines.
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 2099765 to Rexahn, entitled "5, 6, or 7-Substituted-3-arylisoquinolinamine derivatives as antitumor agents."
The National Organization for Rare Disorders and other leading disease and disabilities advocacy groups have filed an amicus brief urging the courts to protect Americans from lawsuits that would undermine protections provided by the nation's new health care reform legislation.
Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.
› Verified 8 days ago
Shagufta Ahsan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |